Metropolitan Life Insurance Company (MetLife)’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-187
| Closed | -$21K | – | 1316 |
|
|
2024
Q1 | $21K | Buy |
187
+125
| +202% | +$14K | ﹤0.01% | 1837 |
|
|
2023
Q4 | $3.62K | Sell |
62
-142
| -70% | -$8.28K | ﹤0.01% | 2302 |
|
|
2023
Q3 | $6.49K | Hold |
204
| – | – | ﹤0.01% | 2369 |
|
|
2023
Q2 | $16.8K | Buy |
204
+49
| +32% | +$4.04K | ﹤0.01% | 2023 |
|
|
2023
Q1 | $16K | Sell |
155
-105
| -40% | -$10.8K | ﹤0.01% | 1990 |
|
|
2022
Q4 | $38.1K | Buy |
260
+70
| +37% | +$10.3K | ﹤0.01% | 1637 |
|
|
2022
Q3 | $32.2K | Hold |
190
| – | – | ﹤0.01% | 1754 |
|
|
2022
Q2 | $22K | Hold |
190
| – | – | ﹤0.01% | 2008 |
|
|
2022
Q1 | $19K | Sell |
190
-191
| -50% | -$19.1K | ﹤0.01% | 2123 |
|
|
2021
Q4 | $59.2K | Sell |
381
-217
| -36% | -$33.7K | ﹤0.01% | 2684 |
|
|
2021
Q3 | $141K | Sell |
598
-193
| -24% | -$45.5K | ﹤0.01% | 2321 |
|
|
2021
Q2 | $269K | Buy |
791
+207
| +35% | +$70.3K | ﹤0.01% | 1945 |
|
|
2021
Q1 | $236K | Sell |
584
-49
| -8% | -$19.8K | ﹤0.01% | 1903 |
|
|
2020
Q4 | $421K | Buy |
633
+14
| +2% | +$9.32K | 0.01% | 1466 |
|
|
2020
Q3 | $288K | Buy |
619
+45
| +8% | +$21K | ﹤0.01% | 1564 |
|
|
2020
Q2 | $336K | Buy |
574
+366
| +176% | +$214K | 0.01% | 1476 |
|
|
2020
Q1 | $30.3K | Buy |
+208
| New | +$30.3K | ﹤0.01% | 2421 |
|